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Human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) provide an unlimited source for the
generation of human hepatocytes, owing to their indefinite self-renewal and pluripotent properties. Both hESC-/
iPSC-derived hepatocytes hold great promise in treating liver diseases as potential candidates for cell replacement
therapies or as an in vitro platform to conduct new drug trials. It has been previously demonstrated that the initiation
of hESC differentiation in monolayer cultures increases the generation of definitive endoderm (DE) and subse-
quently of hepatocyte differentiation. However, monolayer culture may hinder the maturation of hESC-derived
hepatocytes, since such two-dimensional (2D) conditions do not accurately reflect the complex nature of three-
dimensional (3D) hepatocyte specification in vivo. Here, we report the sequential application of 2D and 3D culture
systems to differentiate hESCs to hepatocytes. Human ESCs were initially differentiated in a monolayer culture to
DE cells, which were then inoculated into Algimatrix scaffolds. Treatments of hESC-DE cells with a ROCK inhibitor
before and after inoculation dramatically enhanced their survival and the formation of spheroids, which are distinct
from HepG2 carcinoma cells. In comparison with monolayer culture alone, sequential 2D and 3D cultures signifi-
cantly improved hepatocyte differentiation and function. Our results demonstrate that hESC-DE cells can be in-
corporated into Algimatrix 3D culture systems to enhance hepatocyte differentiation and function.
Introduction
The liver plays an essential role in metabolism, detoxi-fication, and maintenance of homeostasis in the body.
Many of these functions are executed by the hepatocytes, the
primary cell type constituting the liver. Currently, the only
available treatment for the liver failure is liver transplanta-
tion, which is severely limited by the shortage of liver donors.
Therefore, hepatocyte transplantation has been considered as
a putative alternative treatment and has attracted increasing
attention, particularly in recent years with the development
of human embryonic stem cells (hESCs) and induced plu-
ripotent stem cells (iPSCs), as these cells could potentially
provide an unlimited source for the generation of human
hepatocytes.1,2 In addition to hepatocyte transplantation,
stem cell-derived functional human hepatocytes also have the
potential to be a valuable cell source for the development of a
bioartificial liver3,4 as well as for providing an easily acces-
sible in vitro model for determining the metabolic and toxi-
cological properties of potential drugs in humans, a key need
unmet in current pharmaceutical development.5 Unlike
transplantation, in which hepatic progenitor cells can be
further differentiated in vivo, these later applications require
more matured hepatocytes, which are proficient in the func-
tions of adult liver cells, especially in their metabolic func-
tions and toxicological responses to different drug treatments.
Over the last decade, significant progress has been made
in developing methods to differentiate pluripotent stem cells
efficiently to hepatocyte-like cells (HLCs), through the se-
quential application of growth factors that are known to play
an important role at various stages of liver development.6–9
The resulting HLCs exhibit a typical hepatocyte morphology,
express almost all the hepatocyte markers, and perform a
wide range of hepatocyte functions. However, the function-
ality of in vitro differentiated hepatocytes is lower than in
primary hepatocytes. This is hardly surprising, given that
functional performance of primary hepatocytes deteriorates
after a short period in culture,10 indicating that the culture
conditions in these experiments are suboptimal for promot-
ing and maintaining hepatocyte functionality. Therefore,
there is a need to improve hepatocyte differentiation and
culture conditions to enhance their functionality.
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The majority of studies to date involving hepatocyte dif-
ferentiation have been carried out in two-dimensional (2D)
monolayer culture conditions throughout,6,7,11 or have been
initiated with embryoid body (EB) formation, followed by
2D cultures.12 Monolayer culture is thought to have certain
advantages over EB formation for the efficient differentiation
of pluripotent stem cells to specific lineages, as it enables all
the cells to receive a similar level of stimuli from the culture
medium and neighboring cells, compared with EB initiation,
where cells receive a diverse range of signal inputs de-
pending on their location within the EB. This difference may
be especially crucial for the efficient generation of definitive
endoderm (DE), since high levels of the growth factor Acti-
vin A through supplementation in the culture medium are
necessary for the specification of hESCs to DE cells.13 How-
ever, since liver development is also regulated by cell–cell
contact, the absence of suitable cell contacts in the 2D culture
conditions may contribute to the reduced functionality. In-
deed, it has been demonstrated that a three-dimensional (3D)
culture can reduce the hepatocyte functional decline that is
seen using the 2D culture system.14 Therefore, we hypothe-
sized that transference from an initial 2D culture condition to
a 3D system would significantly improve hepatocyte matu-
ration and concurrently their functionality. Here, we report
the differentiation of hESCs to hepatocytes utilizing a com-
bination of 2D and 3D culture systems. We demonstrate that
DE cells derived from monolayer differentiation of hESCs
have the ability to form aggregates in Algimatrix scaffold 3D
culture when treated with a Rho-associated kinase (ROCK)
inhibitor. Residing in this 3D culture microenvironment
therefore enhances subsequent hepatocyte maturation,
leading to a clear improvement in their functionality.
Materials and Methods
Culture and differentiation of hESCs
The hESC line H1 was routinely cultured and propagated
in Matrigel-coated plates with a mouse embryonic fibroblast-
conditioned medium supplemented with basic fibroblast
growth factor as previously described.15 hESCs were differ-
entiated into hepatocytes in monolayer culture using the
protocol previously established in our laboratory (Fig. 1A).7
Briefly, differentiation was initiated by culturing for 24 h
with 100 ng/mL Activin A and 1mM sodium butyrate
(NaB), followed by 2 days with 100 ng/mL Activin A and
0.5mM NaB. The cells were then cultured for 5 days in a
stage II medium containing 20% KO serum replacement and
0.1% dimethyl sulfoxide (DMSO), followed by 4–5 days in
stage III medium (L15 medium containing 8.3% fetal bovine
serum, 8.3% tryptose phosphate broth, 10mM hydrocortisone
21-hemisuccinate, 1mM insulin and 2mM glutamine, 10 ng/
mL hepatocyte growth factor, and 20 ng/mL Oncostatin M).
For 3D differentiation, hESCs were differentiated in the same
medium as in the monolayer cultures until the second day of
stage II when they were inoculated into the Algimatrix plate
(Invitrogen 12684-023) (Fig. 1A). Before inoculation, cells
were treated with 10 mM ROCK inhibitor Y-27632 (ROCKi)
for 2 h before they were detached from the culture dish with
accutase. Viable cells were transferred into a 24-well Algi-
matrix plate by centrifugation at 200 g for 3min at either
0.5 · 106 or 1 · 106 cells per well in a medium also supple-
mented with ROCKi, which was withdrawn after 48 h.
Analysis of the spheroids
Cell spheroids were released from the scaffold by 5-min
incubation with 1mL dissolving buffer (Invitrogen A11340-01)
and were then harvested by centrifugation at 200 g for 4min.
Spheroids were stained by 90 s of incubation with propidium
iodide (PI) resuspended at 40mg/mL in phosphate-buffered
saline (PBS), and images were captured by a Nikon E2000
phase-contrast fluorescent microscope. Dimensional analysis
of the spheroids was performed using images taken under a
phase-contrast microscope and using the medium axis of the
spheroid. To determine the viable cell number, spheroids
were dissociated into single cells by 8–10-min incubation
with trypsin–ethylenediaminetetraacetic acid at 37C, during
which time the spheroids were gently resuspended twice
using a pipette. Single cells were then stained with trypan
blue and counted with a hemocytometer.
RNA extraction and reverse transcription–polymerase
chain reaction
Total RNA was extracted using TRI reagent solution
(Sigma T9424) following the manufacturer’s instructions.
Remaining traces of DNAs were removed by DNase I
treatment. First-strand cDNA was synthesized from 2 mg
FIG. 1. Differentiation of human embryonic stem cells
(hESCs) to hepatocyte-like cells by sequential application of
two-dimensional (2D) and three-dimensional (3D) culture
systems. (A) Schematic illustration of the procedure to dif-
ferentiate hESCs to hepatocytes. Human ESCs were initially
differentiated in a monolayer culture until day 4 (2nd day in
the stage II medium), and then the cells were transferred into
Algimatrix 3D culture system for further differentiation to
hepatocytes. Act, Activin A; FBS, fetal bovine serum; HGF,
hepatocyte growth factor; NaB, sodium butyrate; OSM,
Oncostatin M. (B) Semiquantitative reverse transcription–
polymerase chain reaction (RT-PCR) analysis showing gene
expression in hESCs and their differentiated definitive en-
doderm (hESC-DE) cells before transfer to the 3D culture.
Pluripotent and neural genes are on the left panel, and de-
finitive endoderm genes are on the right panel.
HEPATOCYTE DIFFERENTIATION BY SEQUENTIAL 2D AND 3D CULTURES 361
total RNA using SuperScript II reverse transcriptase (In-
vitrogen) with oligo-dT primer (Invitrogen) in a 20-mL vol-
ume. All primer sequences and polymerase chain reaction
conditions used are listed in Table 1.
CYP3A4 activity assay
Cells cultured in both monolayer and Algimatrix scaffold
conditions were treated with either 10mM rifampicin or 0.1%
DMSO (vehicle only) for 48 h. The spheroids were then re-
leased from the scaffold as described above into a new cul-
ture dish. Subsequently, the cells in both spheroids and
monolayer culture were subjected to the P450-Glo CYP3A4
assay using a Luciferin-IPA kit (Promega V9001) according
to the manufacturer’s instructions. Briefly, cells were incu-
bated for 1 h at 37C with a phenol-free DMEM supple-
mented with 10% fetal bovine serum containing 3mM
Luciferin-IPA after washed with PBS. A medium containing
IPA substrate alone was used as background control. About
50 mL of the resulting medium was transferred to a 96-well
plate containing an equal volume of Luciferin Detection
Reagent and incubated at room temperature for 30min to
initiate the luminescent reaction. The remaining cells were
enzymatically dissociated and quantified via cell count. Ac-
tivity was measured on a Perkin Elmer Victor 2 luminometer.
Values were corrected to account for background. For each
treatment, three independent experiments were performed to
allow statistical analysis.
BrdU incorporation assay
hESC-DE or HepG2 cells were inoculated into an Algima-
trix scaffold with 0.5 million cells per well. After 24 h, BrdU
was added into the medium to a final concentration of 10mM
and incubated for 48h. The spheroids were then released from
the scaffold, dissociated as described above, and placed onto
coverslips. After 24h culture without BrdU, cells were then
fixed by 10-min incubation with 4% paraformaldehyde, wa-
shed with PBS, and treated with 2M HCl for 1 h at 37C. Cells
were then washed and blocked for 1 h in PBS containing 10%
goat serum, incubated with mouse anti-BrdU antibody
(DSHB, 1:1000 dilution) for 1 h, followed by 30-min incubation
with goat anti-mouse IgG Alexa Fluor 568 secondary antibody
(Invitrogen; 1:400 dilution) at room temperature. Images were
taken using a Leica SP5 fluorescent microscope.
Urea secretion assay
Urea secretion was assessed by a colorimetric assay
(DIUR-500 BioAssay Systems) according to the manufactur-
er’s instructions. Briefly, upon a quick thaw of the frozen
supernatants, 50mL water (blank), 50mL standard (5mg/dL),
or 50 mL samples were transferred into triplicate wells of a
clear-bottom 96-well plate. Then, 200mL working reagent
was added, and samples were mixed by gentle tapping.
These were then incubated for 50min at room temperature.
A spectrophotometer plate reader was used to read absor-
bance at 430 nm, and urea secretion was calculated following
the manufacturer’s instructions.
Results
ROCK inhibitor promotes the survival and spheroid
formation of hESC-DE cells in Algimatrix scaffold
Since monolayer culture condition can efficiently differenti-
ate hESCs into DE cells, an essential early stage in the gen-
eration of hepatocytes,7,13 and 3D culture provides a better
cell–cell contact, which enhances hepatocyte differentiation
and function,14 it is plausible to hypothesize that a combination
of the two conditions would greatly enhance the generation of
functional hepatocytes from hESCs. To test this hypothesis, we
initiated DE differentiation in hESCs using monolayer culture
previously established in our laboratory7 (Fig. 1A) and then
incorporated the resulting DE cells into 3D culture. We have
previously shown that using thismonolayer culture, amajority
of the cells were differentiated into DE cells by the end of the
stage I differentiation.7However, due to considerable cell death
that occurs during the 24-h NaB (1mM) treatment, it was dif-
ficult to obtain a sufficient number of cells for the 3D culture at
end of the stage I. Therefore, we continued the differentiation
on monolayer into the stage II for 1 day before subjecting them
into the 3D culture in a bid to increase the number of viable cells
(Fig. 1A). These cells are very similar to those found at the end
of stage I, as they express high levels of the DE markers, Sox17
and FoxA2, but significantly reduced expression of the plu-
ripotent markers, Oct4 and Nanog, with no expression of the
neural marker Pax6 (Fig. 1B). These cells will henceforth be
referred to as hESC-DE cells.
To incorporate cells into 3D culture, hESC-DE cells were
first disassociated into single cells from the culture plate and
Table 1. Primer Sequences for the Reverse Transcription–Polymerase Chain Reaction
Name Forward primer 5¢-3¢ Reverse primer 5¢-3¢ Expected size Ta (C)
Albumin CCTTTGGCACAATGAAGTGGGTAACC CAGCAGTCAGCCATTTCACCATAGG 354 bp 55
APOF GGAAGCGATCAAACCTACCA ATCAGCCTGACAACCAGCTT 347 bp 55
B-Actin TCACCACCACGGCCGAGCG TCTCCTTCTGCATCCTGTCG 350 bp 61
CXCR4 CACCGCATCTGGAGAACCA GCCCATTTCCTCGGTGTAGTT 79 bp 55
Cyp3A4 CCTTACATATACACACCCTTTG GGTTGAAGAAGTCCTCCTAAGCT 169 bp 50
Cyp7A1 GTGCCAATCCTCTTGAGTTCC ACTCGGTAGCAGAAAGAATACATC 397 bp 57
FoxA2 AGATGGAAGGGCACGAGC CAGGCCGGCGTTCATGTT 88 bp 56
GAPDH TCTGCTCCTCCTGTTCGACA AAAAGCAGCCCTGGTGACC 120 bp 55
Nanog AGCCTCTACTCTTCCTACCACC TCCAAAGCAGCCTCCAAGTC 278 bp 60
Oct4 CTTGCTGCAGAAGTGGGTGGAGGAA CTGCAGTGTGGGTTTCGGGCA 167 bp 60
Pax6 AACAGACACAGCCCTCACAAACA CGGGAACTTGAACTGGAACTGAC 275 bp 60
Sox17 CCAGAATCCAGACCTGCACAA CTCTGCCTCCTCCACGAA 100 bp 57
TO GGCAGCGAAGAAGACAAATC TCGAACAGAATCCAACTCCC 218 bp 55
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then inoculated into a 24-well Algimatrix 3D culture plate at
0.5–1 · 106 cells per well. HepG2 cells were also inoculated
into the plate in the same way as hESC-DE cells. Interest-
ingly, spheroids were observed in HepG2 cells after 5 days in
the 3D culture, but none were visible in hESC-DE cultures
(Fig. 2A). PI staining revealed considerable cell death in the
hESC-DE cultures (Fig 2B-upper panel). As the HepG2 cells
grew well in the 3D culture plate, we surmised that the
scaffold itself does not induce any detrimental effect on the
cells that leads to their death. As such, we reasoned that
dissociation of the hESC-DE cells might be the cause of the
high levels of cell death observed postinoculation. It has been
reported previously that dissociation of hESCs into single
cells increases ROCK-dependent hyperactivation of actin–
myosin contraction, which induces apoptosis,16,17 and that
treatment of hESCs with the ROCK inhibitor Y-27632
(ROCKi) significantly reduces apoptosis after dissociation.18
To test whether use of ROCK inhibitor could reduce hESC-
DE cell death after dissociation, the cells were pretreated
with 10mM ROCKi for 2 h before disassociation, and the
treatment was continued for further 48 h after inoculation.
With this treatment, spheroids were clearly observed 24 h
after inoculation and were well formed after 9 days with no
signs of detectable apoptosis (Fig. 2B). By contrast, ROCKi
treatment did not show a significant effect on their ability to
form spheroids in HepG2 cells. These results therefore sug-
gest that hESC-DE cells are different from HepG2 cells and
require the inhibition of the ROCK signaling pathway to
survive and to form 3D structures in Algimatrix scaffold.
hESC-DE cells form spheroid in the 3D culture
via cell aggregation
Since different growth behaviors were observed with
hESC-DE cells and HepG2 cells upon their inoculation into
the Algimatrix scaffold, we next examined how spheroids
are formed in these two cell types, by monitoring the cells
immediately after the inoculation. To our surprise, compact
3D aggregates were already visible in hESC-DE cells 3 h after
inoculation, with larger aggregates formed when more cells
were inoculated, whereas HepG2 cells still appeared as sin-
gle cells or loose-contacted cell clusters at the time (Fig. 3A,
FIG. 2. Effect of ROCK inhibitor
(ROCKi) on cell survival and
spheroid formation of hESC-DE
cells in Algimatrix scaffold. (A)
Both hESC-DE and HepG2 cells
were inoculated into 24-well
Algimatrix at 5 · 105 cells/well.
Images were taken 5 days after
inoculation, showing no spheroids
formed in hESC-DE cultures, but
evidence of spheroids in HepG2
cells. (B) hESC-DE cells were
treated with or without ROCKi
before and 48h after inoculation of
1 · 106 cells/well into the
Algimatrix 3D culture. Cells were
collected 9 days after the
inoculation and stained with
propidium iodide (PI) to detect any
cell death. ROCKi treatment
dramatically reduced the cell death
and enhanced the spheroid
formation. Scale bar = 100 mm. Color
images available online at
www.liebertpub.com/tea
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upper panel). By 24 h in the 3D scaffold, hESC-DE aggregates
appeared as spheroids, and similar spheroids were also ap-
parent in HepG2 cells (Fig. 3A, middle panel). The size of
spheroids in the hESC-DE cells did not change significantly,
whereas the spheroids in the HepG2 cells gradually in-
creased in size during the first 48 h in 3D culture (Fig. 3A,
lower panel). These data suggest that hESC-DE cells may
form spheroids predominantly via cell aggregation, which
can occur within a relatively short time period and may be
promoted by a ROCK inhibitor, whereas HepG2 cells may
form spheroids through cell aggregation as well as cell pro-
liferation.
To validate this observation, we compared the total viable
cell numbers seeded at inoculation with those after 9 days of
3D culture in both cell types. As expected, the number of
viable HepG2 cells in the 3D culture notably increased dur-
ing this time period, although not to the same extent as in the
2D culture, whereas the number of hESC-DE cells showed a
decrease in numbers, most likely due to cell death (Fig. 3B).
To further confirm the proliferative properties of the two cell
types, we incubated the cells with BrdU for 48 h after 3D
inoculation, and then stained the cells with an anti-BrdU
antibody. HepG2 cells showed positive signals with the
BrdU antibody, whereas positive staining was not detected
in the nuclei of hESC-DE cells. Therefore, these results con-
firm that hESC-DE cells do not proliferate after inoculation
into the Algimatrix scaffold.
Cell density affects the size of spheroids
in the Algimatrix scaffold
Spheroid size has been reported to affect hepatocyte via-
bility and function in the 3D culture.14 Since the cell spher-
oids in culture do not have a vascular network, cells
constituting the center of the spheroids become hypoxic and
have a reduced uptake of oxygen from the cell medium if
they are larger than 100 mm in size. On the other hand, if the
spheroid size is too small, they produce significantly less
albumin as a result of poor maturation.19 To study factors
that affect the spheroid size, we categorized the spheroids
produced by our 3D culture into three groups according to
their size: small with spheroids of < 50mm in diameter, me-
dium between 50 and 100 mm in diameter, and larger over
100 mm in diameter, and examined the effect of initial inoc-
ulation seeding density on the spheroid size. We measured
and categorized *100 spheroids from each inoculation
condition 9 days after the cells were inoculated. The results
show that in hESC-DE cells, a majority (84%) of spheroids
FIG. 3. Spheroid formation
and cell proliferation in
Algimatrix 3D cultures. (A)
Both hESC-DE and HepG2
cells aggregate to form
spheroids during the first day
after inoculation into the
Algimatrix scaffold with
hESC-DE cells forming
aggregates quicker than the
HepG2 cells and higher
seeding density producing
larger spheroids. In addition,
spheroids formed by hESC-
DE cells exhibit no significant
difference in size between 24–
48 h, while spheroids of
HepG2 cells show clear
increase during this time
period. Scale bar = 100 mm. (B)
Changes in cell number after
9 days in 3D culture. Cell
counts are presented as
percentage of the initial
seeded cell numbers.
Standard error bars were
calculated from six
independent experiments.
**p< 0.001 (Student’s t-tests).
(C) BrdU-labeling assay.
Spheroids were incubated
with BrdU for 48 h and then
dissociated onto a coverslip
for further 24 h before stained
with an antibody against
BrdU. Scale bar = 25 mm.
Color images available online
at www.liebertpub.com/tea
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produced from the lower seeding density of 5· 105 cells/well
fell into the medium-size bracket, with < 10% of spheroids
falling into the larger- or smaller-size group. However, at
higher seeding density of 1· 106 cells/well, almost 20% and
30% of the spheroids were in the large- and smaller-size
group, respectively, with < 60% in the medium-size category
(Fig. 4). In HepG2 cells, the lower seeding density of 5 · 105
cells/well produced very few spheroids (< 5%) of the large
size. These results suggest that the initial seeding density of
hESC-DE cells has an effect on the sizes of the spheroids
formed in the 3D scaffold.
Algimatrix 3D culture promotes hepatocyte
differentiation and function
Alginate scaffold has been found to promote cells from the
liver of newborn rats to differentiate into functional liver
tissues.20 To evaluate whether the Algimatrix 3D culture has
any advantage over monolayer culture in differentiating DE
cells into hepatocytes, we compared the hepatic gene ex-
pression profiles in the 3D culture to those in monolayer as
well as to undifferentiated hESCs and the hESC-DE cells
used at the 3D inoculation stage. Unsurprisingly, undiffer-
entiated hESCs exhibited high levels of the pluripotent gene
Oct4, but showed no expression of hepatic markers. Ex-
pression of the DE marker, Sox17, was apparent in hESC-DE
cells, but neither Oct4 nor any hepatic genes were detectable.
In contrast, hESC-DE cells that had been further differenti-
ated in both 2D and 3D culture conditions expressed the
hepatocyte genes, albumin, apolipoprotein F (ApoF), tryp-
tophan dioxygenase (TO), and cytochrome P450 family
members, CYP3A4 and CYP7A1 (Fig. 5A). Significantly, the
cells differentiated in the Algimatrix 3D scaffold exhibited
considerably higher levels of hepatocyte-specific markers
than the cells differentiated in monolayer, particularly those
that are expressed predominantly in the more mature he-
patocytes, such as ApoF, TO, and CYP3A4.21
Since CYP3A4 is the most crucial P450 enzymes in the
human liver, metabolizing about half of all drugs on the
market today, we examined CYP3A4 activity in hESC-DE
and HepG2 cells that were either cultured in 3D conditions
or differentiated in monolayer to further determine the im-
provement of 3D culture on the differentiation and function
of hepatocytes. In comparison with the monolayer culture
system, at the lower seeding density of 0.5 · 106 cells/well,
Algimatrix 3D culture significantly increased basal levels of
CYP3A4 activity in both hESC-DE cells and HepG2 cells (Fig.
5B). The higher inoculation density also increased activity,
but to a lesser extent, probably due to a suboptimal spheroid
size. Furthermore, the cells cultured in the 3D condition also
exhibited increased CYP3A4 activity in response to rifam-
picin induction (Fig. 5C). To further validate the improve-
ment of 3D culture on hepatocyte differentiation and
function, we measured urea secretion in hESC-derived he-
patocytes from both 2D and 3D cultures (Fig. 5D), which
showed that Algimatrix 3D culture significantly enhanced
urea secretion when hESC-DE cells were seeded at 0.5 · 106
cells/well. Taken together, we have shown that Algimatrix
3D culture system improves the differentiation of hESC-DE
cells to hepatocytes, and as a result, enhances the expression
of hepatocyte markers and certain functions.
Discussion
We have demonstrated here that DE cells derived from
hESCs are able to form spheroids in an Algimatrix scaffold.
In comparison with the monolayer culture, Algimatrix 3D
culture enhances hepatocyte differentiation and function.
These results correspond with the previous findings from
hESCs.9 However, in the previous studies, the 3D culture
was directly applied to the hESCs, in which hESCs were
detached into small clumps and cultured in a low-adherent
plate to form EBs. Since pluripotent hESCs in the EBs receive
variable signals depending on their position, this method
may have an increased chance of inducing the differentiation
of cells to other lineages, which consequently reduces the
final yield of hepatocytes. Our previous studies, as well as
those of others, have shown that monolayer culture supple-
mented with high-dosage Activin A can differentiate hESCs
efficiently to the DE cells that are a prerequisite for the
generation of hepatocytes.7,13 Therefore, to increase hepato-
cyte production, we incorporated the 3D culture at a later
stage in the differentiation protocol, once the hESCs were
committed to DE. We differentiated hESCs for 4 days in
monolayer culture with our established method and dem-
onstrated that the cells were primarily differentiated into DE
(Fig. 1B) before incorporating them into 3D culture.
Here, and in accordance with others, we have demon-
strated that an alginate-based 3D culture system can enhance
the functionality of HepG2 cells and has no toxic effects on
the cells.22,23 Interestingly, we have also shown that hESC-
DE cells behave differently from HepG2 cells when cultured
in an Algimatrix 3D scaffold. Firstly, hESC-DE cells required
the treatment of ROCKi to survive in the 3D culture after
dissociation, whereas HepG2 cells do not require ROCKi to
survive or to form spheroids. In addition, treatment of
HepG2 cells with ROCKi showed no effect on their survival
and proliferation. This phenotype of hESC-DE cells is similar
to that reported in undifferentiated hESCs.24 In hESCs,
FIG. 4. Effect of seeding density on spheroids’ sizes.
Spheroids from each culture were released after 9 days in the
Algimatrix scaffold, and their size was measured from im-
ages taken with a phase-contrast microscope as described in
the Materials and Methods section. At least 100 randomly
selected spheroids were measured from each culture condi-
tion and grouped according to their size.
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apoptosis upon dissociation is thought to be caused by
ROCK-dependent actomyosin hyperactivation, which is
triggered by the loss of E-cadherin-dependent intercellu-
lar contact.17 However, hESC-DE cells stained with anti-E-
cadherin antibody exhibited no clear positive signals (data
not shown), indicating that the apoptosis induced by disso-
ciation in hESC-DE cells is not a downstream effect of
E-cadherin. Nonetheless, one cannot exclude the possibility
that this phenotype could still be related to the loss of
attachment-dependent actin–myosin contraction.16 Further
experiments are required to elucidate the underlying mech-
anisms. Secondly, hESC-DE cells aggregate more rapidly
than the HepG2 cells. Thirdly, unlike HepG2 cells, hESC-DE
cells were unable to proliferate in the Algimatrix 3D scaffold,
which was demonstrated by the fact that there was no sig-
nificant increase in the cell numbers after 9 days in the 3D
culture, and that BrdU labeling showed no incorporation
(Fig. 3). This was also different from their behavior in
monolayer culture, in which hESC-DE cells were able to di-
vide and incorporate BrdU. Although the exact mechanisms
remain unclear, it has been demonstrated previously that the
growth properties and differentiated functionality of rat he-
patocytes are reciprocally modulated in culture by cell–cell
contact, and that this reciprocal modulation is lost in hepa-
toma cells.25,26 Therefore, it is likely that increased cell–cell
contact may account for the phenotype, which may also
contribute to the improved differentiation and functionality.
We have analyzed spheroid formation and hepatocyte
function of hESC-DE cells at two different seeding densities.
The two different seeding densities did not seem to have a
clear effect on the timing of spheroid formation, but did
appear to impact the size of spheroids formed in the Algi-
matrix scaffold. However, this effect was not a simple posi-
tive correlation. Surprisingly, the higher seeding density not
only resulted in a higher proportion of the larger spheroids
but also increased the number of smaller spheroids. In ad-
dition, our results showed that lower seeding densities that
generated significantly more medium-sized spheroids had
higher levels of CYP3A4 activity and a significant induction
upon drug stimulation as well as increased urea secretion,
indicating that the size of hESC-DE spheroids is important
for the hepatocyte differentiation and function. It is not
surprising that it is the medium-sized spheroids that exhibit
better functionality, as the larger size reduces the nutrition/
oxygen accessibility of the cells found at the center and af-
fects the survival of these cells; while the smaller spheroids
do not form the proper cell–cell contacts, which may sub-
sequently hinder hepatocyte differentiation and function.19
In summary, our study has demonstrated that hESC-DE cells
can be incorporated into an Algimatrix scaffold 3D culture
upon treatment with the ROCK inhibitor. The 3D culture
enhances hESC-DE cell differentiation to HLCs and im-
proves the resulting hepatocyte function, such as CYP3A4
activity.
Acknowledgments
We thank Dr. Sam Coward and Dr. Isobel Massie for their
technical help and discussion at early stage of the project and
thank Dr. Fiona Lamont for their helpful discussion on the
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protein F; TO, tryptophan dioxygenase. Total RNAs without RT exhibited no signals with all primers. (B) Algimatrix 3D
cultures enhance CYP3A4 activity in both hESC-DE and HepG2 cells. Cells were seeded into the 3D Algimatrix plate at
0.5 · 106 (3D-0.5) or 1· 106 (3D-1) cells per well and differentiated for 9 days, CYP3A4 activity was then measured as
described in the Materials and Methods section. Error bars were calculated from three independent experiments. *p< 0.01 and
**p< 0.005 (Student’s t-test). (C) Increase of CYP3A4 activity in hESC-DE-derived hepatocytes in response to rifampicin
treatments. *p < 0.05. (D) Urea secretion in hESC-DE-derived hepatocytes from 2D and Algimatrix 3D cultures seeded at
0.5 · 106 (3D-0.5) or 1· 106 (3D-1) cells per well. Error bars were calculated from three independent experiments. *p< 0.01.
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